Haptenation: chemical reactivity and protein binding
- PMID: 21785613
- PMCID: PMC3138048
- DOI: 10.1155/2011/839682
Haptenation: chemical reactivity and protein binding
Abstract
Low molecular weight chemical (LMW) allergens are commonly referred to as haptens. Haptens must complex with proteins to be recognized by the immune system. The majority of occupationally related haptens are reactive, electrophilic chemicals, or are metabolized to reactive metabolites that form covalent bonds with nucleophilic centers on proteins. Nonelectrophilic protein binding may occur through disulfide exchange, coordinate covalent binding onto metal ions on metalloproteins or of metal allergens, themselves, to the major histocompatibility complex. Recent chemical reactivity kinetic studies suggest that the rate of protein binding is a major determinant of allergenic potency; however, electrophilic strength does not seem to predict the ability of a hapten to skew the response between Th1 and Th2. Modern proteomic mass spectrometry methods that allow detailed delineation of potential differences in protein binding sites may be valuable in predicting if a chemical will stimulate an immediate or delayed hypersensitivity. Chemical aspects related to both reactivity and protein-specific binding are discussed.
Figures
References
-
- Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Current Opinion in Allergy and Clinical Immunology. 2002;2(4):301–305. - PubMed
-
- Cronin MT, Basketter DA. Multivariate QSAR analysis of a skin sensitization database. SAR & QSAR in Environmental Research. 1994;2(3):159–179. - PubMed
-
- Gerberick GF, Ryan CA, Kern PS, et al. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis. 2005;16(4):157–202. - PubMed
-
- Kern PS, Gerberick GF, Ryan CA, Kimber I, Aptula A, Basketter DA. Local lymph node data for the evaluation of skin sensitization alternatives: a second compilation. Dermatitis. 2010;21(1):8–32. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
